Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium
Study Details
Study Description
Brief Summary
This study aims to investigate whether a change in the pattern of hospitalisation was observed in paediatric wards over the last 6 years (June 2004 - May 2010), whether a change in staff workforce availability was observed in paediatric wards over the last 6 years (during a whole year or during specific time periods of the year) and if changes of any of the variables measured during the observation period could be linked to the introduction of rotavirus vaccination.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This retrospective study will use data extracted from hospital databases during the period of the 1st of June 2004 until the 31st of May 2010. A coded list of all hospitalisations and of the different infection tests performed in children will be generated, together with a list of Full time equivalents (FTE) in paediatric ward and the number of sick leave days of the working personnel.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Hospitalized Group Data collection for changes in hospital pattern pre- versus post-rotavirus vaccination, in children ≤15 years old hospitalised for any reason between June 2004 and May 2010. |
Other: Data collection
The participating centre will be requested to generate a coded list of all hospitalisations taken place during the study period (June 1st 2004- May 31st 2010) and analysed for changes in hospital pattern pre- versus post-rotavirus vaccination, in children aged ≤15 years.
|
Outcome Measures
Primary Outcome Measures
- Determination of changes in hospitalisation pattern and workforce availability at the level of a pediatric ward in a hospital setting. [During the study period (from June 1st 2004 up to 6 years)]
Secondary Outcome Measures
- Expression of the changes into a quality of hospital care score that can be easily applied in different hospital settings. [During the study period (from June 1st 2004 up to 6 years)]
- Determination through factor and regression analysis which variable influences most the score in order to improve the score calculation. [During the study period (from June 1st 2004 up to 6 years)]
- Investigation of whether a change in the quality of hospital care score could be linked to the introduction of rotavirus vaccination. [During the study period (from June 1st 2004 up to 6 years)]
- Observation of other changes in the hospital organisation as a consequence of a change in the quality of hospital care score. [During the study period (from June 1st 2004 up to 6 years)]
Eligibility Criteria
Criteria
Inclusion Criteria:
- All children aged ≤15 years being hospitalised (with overnight stay or day clinic) for whatever reason during the study period
Exclusion Criteria:
- Not Applicable
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- GlaxoSmithKline
Investigators
- Study Director: GSK Clinical Trials, GlaxoSmithKline
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 116721